SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001723963-21-000005
Filing Date
2021-11-24
Accepted
2021-11-24 12:27:54
Documents
1
Effectiveness Date
2021-11-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6829
  Complete submission text file 0001723963-21-000005.txt   7861
Mailing Address 1001 WILLIAM MOORE DRIVE RALEIGH NC 27606
Business Address 1001 WILLIAM MOORE DRIVE RALEIGH NC 27606 919-513-6157
BreStem Therapeutics, Inc. (Filer) CIK: 0001723963 (see all company filings)

IRS No.: 821935111 | State of Incorp.: NC | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-405341 | Film No.: 211443709